HIKAL

HealthcareDrug Manufacturers - Specialty & GenericSmall Cap
Hikal Limited

Hikal Limited operates in the Healthcare sector, specifically as a Drug Manufacturer - Specialty & Generic. The company manufactures and sells chemical intermediates, specialty che...

हिन्दी में

Hikal Limited स्वास्थ्य सेवा क्षेत्र में एक स्पेशलिटी और जेनेरिक दवा निर्माता के रूप में कार्यरत है। यह कंपनी विभिन्न उद्योगों जैसे फार्मास्युटिकल, बायोटेक्नोलॉजी, फसल संरक्षण और प...

₹213.66+0.68%1D
Previous trading day close · Data updates after market close
1W: -0.4%
1M: -11.2%
6M: +16.9%
1Y: -15.6%
41/100
Below AvgResearch Score
Market Cap
₹2.6K Cr
Small Cap
P/E Ratio
-56.12
Negative earnings
P/B Ratio
2.17
Reasonable
ROE
7.4%
Weak
ROCE
-0.9%
Average
Debt / Equity
0.61
Moderate
Div. Yield
0.3%
EV/EBITDA
23.61
Fair
52W Low: ₹146.25Current: ₹213.6652W High: ₹261
At 59% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
41/100
Growth
Revenue, EPS, profit growth
24/100
Valuation
PE, PB, EV/EBITDA vs sector
49/100
Risk
Debt levels, volatility, coverage
56/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
-56.12(Negative earnings)
Forward P/E
37.64(Premium)
P/B Ratio
2.17(Reasonable)
P/S Ratio
1.59(Good)
EV/EBITDA
23.61(Expensive)
Dividend Yield
0.3%
5Y CAGR
-15.8%(Moderate)
Revenue Growth
-7.5%(Moderate)
Profitability
ROE
7.4%(Average)
ROCE
-0.9%(Average)
ROA
3.6%(Average)
Net Margin
-2.8%(Low)
EBITDA Margin
8.6%
Financial Health
Debt to Equity
0.61(Moderate)
Current Ratio
1.26(Tight)
Quick Ratio
0.84(Tight)
Interest Coverage
-0.26x(Low)
Technical Indicators
Based on previous trading day close
RSI (14)
42(Neutral)
RSI Exp (14)
46(Neutral)
MACD
-1.193(Bearish)
MACD Signal
-0.339
BB Position
25%(Middle)
BB Width
13.29%(Normal)
ADX (14)
32.0(Strong trend)
Williams %R
-80.8(Oversold)
MFI (14)
42(Neutral)
CCI (20)
-92(Neutral)
Stoch %K
19(Oversold)
ATR (14)
10.80(Avg True Range)
OBV (M)
175.3(Positive)
1W OBV Chg
-0.1%(Decreasing)
Rel Volume
0.20x(Low activity)
Volatility
45.7%(High)
Max DD 1Y
-66.9%(High loss)
EMA 200
222.3
EMA 50
219.3
SMA 200
205.6
vs SMA 50
-2.9%(Below SMA50)
vs SMA 200
3.9%(Above SMA200)
Volume
2.93L
Avg Vol 3M
14.4L
Shareholding Pattern
Promoter
68.9%
High confidence
FII
1.4%
DII / MF
7.2%
Share HIKAL
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.